MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Real world application of alpha-synuclein skin biopsy in the diagnosis of synucleinopathies at a tertiary care center

    C. Yu, C. Cooper (Nashville, USA)

  • Real-life experience with continuous subcutaneous foslevodopa/foscarbidopa infusion in advanced stage of Parkinson’s disease at Villa Margherita

    G. Nordera, N. Bonetto, F. Perini (Vicenza, Italy)

  • Real-World Adverse Event Profile in Children and Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists (D2RAs) Compared With Non-D2RAs

    K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Bethesda, USA)

  • Real-World Clinical and Safety Outcomes from a Prospective, Multicenter Deep Brain Stimulation Registry of Essential Tremor Patients

    G. Deuschl, P. Schuurman, G. Loret, N. Kovacs, M. Barbe, M. Blazquez Estrada, F. Clement, S. Jauma Classen, J. Lee, J. Volkmann, D. Pedrosa, A. Oliviera, S. Paschen, L. Chen, R. Shivacharan, E. Goldberg (Kiel, Germany)

  • Real-World Effectiveness of the 4-Week Patient Deutetrabenazine-Titration Kit for Tardive Dyskinesia Across Races: START Study Post Hoc Analysis

    A. Cutler, G. Alva, M. Konings, S. Finkbeiner, K. Anderson (Lakewood Ranch, USA)

  • Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders

    S. Manohar, J. Jacobe, R. Berger, J. Jankovic, M. Hull (Houston, USA)

  • Real-World USA Outcomes in Patients Implanted with DBS Systems Capable of Directionality and Multiple Independent Current Control

    M. Okun, K. Foote, T. Zesiewicz, Y. Bezchlibnyk, A. Papanastassiou, O. Vaou, J. Carlson, J. Aldred, V. Krishna, B. Dalm, J. Durphy, J. Pilitsis, L. Verhagen Metman, S. Sani, D. Kern, S. Ojemann, R. Ramdhani, D. Weintraub, B. Sundaram, A. Siadati, D. Martinez, C. Zhao, M. Siddiqui, S. Tatter, L. Chen, R. Shivacharan, E. Goldberg (Gainesville, USA)

  • Redefining the Finger-tapping Test in Parkinsonian Patients: Finger to Crease Instead of Finger-to-tip

    F. Akhoundi, Y. Bordelon, J. Leverenz, P. Oikonomou, I. Litvan (San Diego, USA)

  • Reduced Falls With ND0612: Supportive Analyses From the BouNDless Phase 3 Study

    S. Isaacson, F. Stocchi, A. Ellenbogen, N. Lopes, N. Sasson, J. Pereira, O. Rascol (Boca Raton, USA)

  • Reduced plasma levels of small HDL subfractions in advanced Parkinson’s disease

    CM. Chen, KH. Chang, ML. Cheng (Taoyuan, Taiwan)

  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley